Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer

We report the association of CDH1/E-cadherin mutations with cleft lip, with or without cleft palate (CLP), in two families with hereditary diffuse gastric cancer (HDGC). In each family, the CDH1 mutation was a splicing mutation generating aberrant transcripts with an in-frame deletion, removing the extracellular cadherin repeat domains involved in cell-cell adhesion. Such transcripts might encode mutant proteins with trans-dominant negative effects. We found that CDH1 is highly expressed at 4 and 5 weeks in the frontonasal prominence, and at 6 weeks in the lateral and medial nasal prominences of human embryos, and is therefore expressed during the critical stages of lip and palate development. These findings suggest that alteration of the E-cadherin pathway can contribute to human clefting.

[1]  David N. Messina,et al.  Gene expression in pharyngeal arch 1 during human embryonic development. , 2005, Human molecular genetics.

[2]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[3]  Philip Stanier,et al.  Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. , 2004, Human molecular genetics.

[4]  M. Ligtenberg,et al.  Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour , 2004, Oncogene.

[5]  Carla Oliveira,et al.  Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. , 2003, Human molecular genetics.

[6]  J. Klingelhöfer,et al.  Dynamic Interplay between Adhesive and Lateral E-Cadherin Dimers , 2002, Molecular and Cellular Biology.

[7]  C. Caldas,et al.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. , 2001, The New England journal of medicine.

[8]  K. Tachibana,et al.  Two Cell Adhesion Molecules, Nectin and Cadherin, Interact through Their Cytoplasmic Domain–Associated Proteins , 2000, The Journal of cell biology.

[9]  J. Willis,et al.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer , 2000, Nature Genetics.

[10]  R. Spritz,et al.  Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia , 2000, Nature Genetics.

[11]  A. Vergara,et al.  Cytokeratin, vimentin and E-cadherin immunodetection in the embryonic palate in two strains of mice with different susceptibility to glucocorticoid-induced clefting. , 2000, Journal of craniofacial genetics and developmental biology.

[12]  D. Evans,et al.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.

[13]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[14]  T. Beaty,et al.  Genetics of nonsyndromic oral clefts revisited. , 1996, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[15]  S. Markowitz,et al.  E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer , 1999, Human mutation.

[16]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.